Patient derived CML exosomes activate epidermal growth factor receptor (EGFR) signalling in stromal cells and further increases the expression of SNAI and its targets, MMP9 and IL8 [74]. The gene discussed is EGFR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.